Filtered By:
Management: Mergers and Aquisitions
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 119 results found since Jan 2013.
Jefferson, Magee complete merger
Jefferson Health added its fourth new member since 2015 with the completion of its merger with Magee Rehabilitation Hospital.
The leaders of Jefferson and Magee said Tuesday the integration will enable two organizations, both nationally ranked, to provide “an even higher level of care” to patients regaining independence from spinal cord injury, stroke, brain injury, amputation, multiple sclerosis and/or orthopedic injuries.
Jefferson and Magee have had a clinical affiliation for several decades.…
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2018 Category: Biotechnology Authors: John George Source Type: news
Stryker closes $664m Entellus Medical buy
Entellus Medical (NSDQ:ENTL) said today it closed its $664 million sale to Stryker (NYSE:SYK), becoming a wholly owned subsidiary of the Kalamazoo, Mich.-based medtech firm.
Plymouth, Minn.-based Entellus, founded in 2006, makes a family of minimally invasive balloon device products, including its flagship Xpress device, that are designed to treat blocked sinuses. Earlier this year it closed the $81 million buyout of Spirox and its Latera absorbable nasal implant.
In the deal, Stryker paid $24 per share for each share of Entellus, paying an approximate $664 million for the company.
As part of the completed merger, Ente...
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Otolaryngology Ear, Nose & Throat Entellus Medical Inc. Stryker Source Type: news
HIMSS reports attendance growth for 2018 show
LAS VEGAS - Attendance is up 4% as of the third day of this year's Healthcare...Read more on AuntMinnie.comRelated Reading:
Facebook Live from HIMSS 2018: Day 2
Facebook Live from HIMSS 2018: Day 1
HIMSS: Health info exchange enables better stroke care
HIMSS acquisition expands educational offerings
HIMSS/SIIM paper offers advice on enterprise image viewers
Source: AuntMinnie.com Headlines - March 8, 2018 Category: Radiology Source Type: news
Jan Medical begins coop BrainPulse testing with the US Army
Jan Medical said today that it has launched a cooperative research and development deal with the US Army Medical Materiel Agency to evaluate its BrainPulse device.
Jan Medical’s BrainPulse device is designed to non-invasively capture novel physiological signals through a patient’s cardiac output, used to measure vascular and brain tissue conditions, the company said. The data can be used as an ‘aid to diagnoses’ for multiple indications, including concussion and stroke.
Initial testing as part of the R&D program was completed on March 9, with the first user feedback session conducted today, the Mountain View, ...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Research & Development Jan Medical Source Type: news
Ahead of Shire buyout, Takeda sells joint venture and reportedly plans $20B bond deal
Japanese pharmaceutical giant Takeda is boosting its finances ahead of its costly acquisition of Shire plc, selling its stake in a Chinese joint venture for $280 million and reportedly planning a record $20 billion bond deal.
Takeda announced Monday that it had sold its majority stake in a joint venture called Guangdong Techpool Bio-Pharma Co., which sells drugs for pancreatitis and stroke. The move is part of a broader effort by Takeda to ditch assets outside of its core focus areas, including…
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news
Is There an End in Sight for J & amp;J Divestitures?
Johnson & Johnson has received an offer for its sterilization unit. The New Brunswick, NJ-based company said Fortive is seeking to acquire the business for $2.7 billion.
The sterilization business is part of the Ethicon division and earned about $775 million in sales in 2017. J&J has 120 days to accept the offer and if the deal goes through it could close no later than early 2019.
Fortive said it would finance the acquisition through debt or equity and with available cash. The company said it expects the deal to add to adjusted earnings in the first full year after the transaction.
"As we balance the interests of a...
Source: MDDI - June 11, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Sterilization Source Type: news
Dynatronics taps ex-NinePoint CEO von Jako as chief exec | Personnel Moves – July 11, 2018
Dynatronics said late last month it tapped former NinePoint Medical CEO Christopher von Jako as its new chief executive officer and board member, succeeding Kelvyn Cullimore Jr. who will stay on the company’s board of directors.
Prior to joining Dynatronics, von Jako acted as prez & CEO of NinePoint Medical. Before joining Nine Point, von Jako also served as prez & CEO of NeuroTherm, prez of ActiViews and held positions with medtech companies including Integra LifeSciences, Covidien and Medtronic.
“After thorough succession planning and a comprehensive search process, the board is pleased to have foun...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News AngioDynamics berkshiresterilemanufacturing Corindus Vascular Robotics Dynatronics Corp Guerbet integer MedPlast Medtronic Myomo Inc NinePoint Medical Inc. Pavmed viant Source Type: news
Boston Scientific puts $270m on the table for Claret Medical
Boston Scientific (NYSE:BSX) said today that it agreed to pay as much as $270 million to acquire Claret and its Sentinel device.
Marlborough, Mass.-based Boston Scientific said the deal involves an ip-front cash payment of $220 million and another $50 million pegged to a reimbursement milestone. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage.
After landing CE Mark approval in the European Union in 2014, Santa Rosa, Calif.-based Claret won de novo clearance from the FDA last year for the Sentinel d...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Replacement Heart Valves Wall Street Beat Boston Scientific Claret Medical Inc. Source Type: news
Report: Amazon adds MGH cardiologist Majmudar | Personnel Moves – August 21, 2018
Amazon (NSDQ:AMZN) has picked up well-known cardiologist Dr. Maulik Majmudar for a new role within the company as it looks to continue its foray into healthcare, according to a recent CNBC report.
The announcement was made by Majmudar himself on Twitter, according to the report, though he did not state what his specific role within the company will be.
Prior to joining Amazon, Majmudar served as the associate director of Massachusetts General Hospital’s healthcare transformation lab and lectured at the Massachusetts Institute of Technology, according to the report.
Majmudar has advised tech companies in the past, accord...
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Abbott Amazon BioCardia BioSig Technologies Endologix johnsonandjohnson Lantheus Lumendi Nuvasive personnel-moves Rox Medical royalphilips SetPoint Medical Steris Corp. Xtant Medical Source Type: news
Images in Anesthesiology: Early Identification of Tamponade Using Focused Cardiac Ultrasound
CARDIAC tamponade can be difficult to diagnose because clinical and electrocardiogram findings have low sensitivity and specificity. Intubation and positive pressure ventilation during unrecognized tamponade can lead to hemodynamic instability from decreased venous return and increased right ventricular afterload, compromising right ventricular stroke volume. Focused cardiac ultrasound can rapidly demonstrate sensitive and specific findings of tamponade.1 The increased availability, noninvasiveness, portability, and rapid acquisition of images have made focused cardiac ultrasound an indispensable perioperative tool.2,3
Source: Anesthesiology - October 16, 2018 Category: Anesthesiology Source Type: research
Can Daytime Napping Assist the Process of Skills Acquisition After Stroke?
Winifried Backhaus, Hanna Braass, Christian Gerloff, Friedhelm C. Hummel
Source: Frontiers in Neurology - November 22, 2018 Category: Neurology Source Type: research
Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott Laboratories and the National Institutes of Health have formed an alliance to evaluate applications that could help treat chronic pain and progressive movement disorders, like Parkinson’s disease.
The collaboration is a part of NIH’s BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. The agreement specifically calls for NIH to use the Abbott Park, IL-based company’s neuromodulation technologies for research related to these NIH initiatives to explore their application for chronic p...
Source: MDDI - May 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: R & D Source Type: news
Baxter to Acquire 1 of the 16 Most Promising Private Companies in Medtech
Baxter Healthcare is set to acquire Cheetah Medical, a firm an analyst identified earlier this year as one of 16 disruptive private companies in medtech.
The transaction consists of an upfront cash consideration of $190 million, with potential for an additional $40 million based on clinical and commercial milestones. It is set to close in 4Q19.
Boston and Tel Aviv, Israel-based Cheetah Medical is a major provider of non-invasive hemodynamic monitoring technologies.
The addition of Cheetah Medical is expected to enhance Deerfield, IL-based Baxter’s presence in the specialized patient monitoring space with ...
Source: MDDI - September 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: IV Products Business Source Type: news
AI is a Big Part of Cleveland Clinic ’s 2019 MIS
CLEVELAND – Two words dominated much of the program agenda for Cleveland Clinic’s 2019 Medical Innovation Summit (MIS) on Tuesday – Artificial Intelligence.
From a keynote address from Craig Mundie, Senior Advisor to the CEO, and former Chief Research and Strategy Officer, Microsoft to a session discussing companies with non-traditional approaches to healthcare, the topic of AI was discussed.
But is AI just the latest fad in healthcare? Is it fully-defined? And are there real-world examples to look to, to see AI in action? Richard Zane, MD CIO of University of Colorado ...
Source: MDDI - October 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news
What ’s the Big Deal about Data in Medtech?
Discussion, “Top 5 Things You Need to Know about the Implantable Internet of Things."
Brian Chapman, partner and leader of ZS’s medtech practice of ZS, attributes today’s focus on data to the intersection of two important things:
"A general recognition that understanding more and connecting actions with outcomes will provide feedback and understanding that will drive standards of care. This is not new, but as capabilities rise in data collection, aggregation, and synthesize rise, and coupled with machine learning, the promise of data in healthcare is becoming even more ...
Source: MDDI - December 20, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news
